This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

LEO M. ZIMMERMAN, M.D.; DAVID H. WAGNER, M.D.; HAROLD M. PERLMUTTER, M.D.; GEORGE D. AMROMIN, M.D.

Arch Surg. 1950;60(6):1183-1198.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

MANY OF the controversial aspects of thyroid disease which agitated authors a few years ago have largely become adjusted. With the decrease in the frequency and importance of thyrotoxic goiter, the role of tumors of the thyroid gland is assuming increasing proportions. Because of the almost insuperable difficulties in the histologic differentiation between thyroid hyperplasia and neoplasia on the one hand and between benign and malignant tumors on the other, the whole subject of thyroid gland tumors is extremely confused and chaotic. A complete reevaluation of the entire subject would therefore appear to be in order.

The recent literature has stressed the surprisingly high incidence of carcinoma found in nodular goiters removed at operation. Curiously, this same incidence is not reflected in the statistics on patients dying of thyroid carcinoma nor in the numbers of thyroid cancers encountered in large series of unselected postmortem examinations. This disparity is more striking . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO

Footnotes
Read before the Chicago Surgical Society, May 6, 1949. From the departments of surgery and pathology, Michael Reese Hospital.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?